We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Five Below
FIVE
$12.4B
| $6.07M | 0.08% |
148,649
+134,941
| +984% | +$5.46M |
|
277
Coca-Cola Europacific Partners
CCEP
$48B
| $6.01M | 0.08% |
135,860
+59,038
| +77% | +$2.55M |
|
278
L3Harris
LHX
$53.3B
| $5.98M | 0.08% |
83,303
-81,192
| -49% | -$5.62M |
|
279
KBR
KBR
$4.58B
| $5.91M | 0.08% |
+348,475
| New | +$6.25M |
|
280
Hain Celestial
HAIN
$50.3M
| $5.88M | 0.08% |
+100,935
| New | +$5.46M |
|
|
RKT
281
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $5.8M | 0.08% |
95,096
+79,540
| +511% | +$4.31M |
|
|
RLYP
282
DELISTED
RELYPSA INC COM
RLYP
| $5.69M | 0.08% |
184,825
+168,649
| +1,043% | +$4.01M |
|
283
Booking.com
BKNG
$160B
| $5.69M | 0.08% |
124,725
-376,625
| -75% | -$17M |
|
284
Teva Pharmaceuticals
TEVA
$40.5B
| $5.67M | 0.07% |
98,580
-282,318
| -74% | -$15.7M |
|
|
FNSR
285
DELISTED
Finisar Corp
FNSR
| $5.65M | 0.07% |
291,024
-694,146
| -70% | -$11.9M |
|
286
Navient
NAVI
$852M
| $5.63M | 0.07% |
+260,761
| New | +$5.21M |
|
287
Methode Electronics
MEI
$612M
| $5.57M | 0.07% |
152,620
+36,764
| +32% | +$1.38M |
|
288
Credit Acceptance
CACC
$6.2B
| $5.55M | 0.07% |
+40,706
| New | +$5.75M |
|
|
PRAH
289
DELISTED
PRA Health Sciences, Inc.
PRAH
| $5.55M | 0.07% |
+229,271
| New | +$5.17M |
|
290
Progressive
PGR
$124B
| $5.5M | 0.07% |
203,804
-90,178
| -31% | -$2.38M |
|
|
CTXS
291
DELISTED
Citrix Systems Inc
CTXS
| $5.5M | 0.07% |
+108,182
| New | +$5.59M |
|
292
Cummins
CMI
$89.7B
| $5.41M | 0.07% |
37,523
+24,628
| +191% | +$3.48M |
|
|
KNGT
293
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $5.39M | 0.07% |
+160,037
| New | +$5.39M |
|
294
Repligen
RGEN
$8.95B
| $5.37M | 0.07% |
271,005
+64,764
| +31% | +$1.45M |
|
295
CNO Financial Group
CNO
$5.16B
| $5.33M | 0.07% |
309,424
+100,665
| +48% | +$1.73M |
|
|
HCT
296
DELISTED
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
| $5.31M | 0.07% |
446,400
+216,400
| +94% | +$2.46M |
|
|
DTV
297
DELISTED
DIRECTV COM STK (DE)
DTV
| $5.31M | 0.07% |
61,250
+27,286
| +80% | +$2.35M |
|
298
Nordic American Tanker
NAT
$1.3B
| $5.31M | 0.07% |
+531,465
| New | +$4.56M |
|
299
Dana Inc
DAN
$3.01B
| $5.26M | 0.07% |
+242,172
| New | +$4.89M |
|
300
Itaú Unibanco
ITUB
$90.5B
| $5.25M | 0.07% |
1,005,670
+583,726
| +138% | +$3.28M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.